Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Ductal Carcinoma In Situ
Interventions: OTHER: Laboratory Biomarker Analysis|DRUG: Nelipepimut-S Plus GM-CSF Vaccine|BIOLOGICAL: Sargramostim|PROCEDURE: Surgical Procedure
Sponsor: National Cancer Institute (NCI)